Pros and Cons of MHC Polymorphisms

The high level of polymorphism observed in the genes of the major histocompatibility complex (MHC), particularly the class I and class II genes, is beneficial for the survival of a species from an evolutionary standpoint and presents challenges in organ transplantation.

Benefits of MHC Polymorphism for Species Survival:

1. Pathogen Recognition and Immune Defense: MHC polymorphism ensures that a diverse range of pathogen-derived peptides can be presented to T cells, allowing for effective immune responses against a wide variety of pathogens. This diversity enhances the ability of a population to combat infections and reduces the risk of pathogen evasion.
2. Hybrid Vigor and Genetic Diversity: MHC polymorphism contributes to genetic diversity within populations, including diversity at the cellular and individual levels. This genetic diversity promotes hybrid vigor, which enhances the overall fitness and adaptability of the population to changing environmental conditions.
3. Avoidance of Inbreeding Depression: High MHC polymorphism reduces the likelihood of inbreeding depression, a phenomenon where offspring of closely related individuals exhibit reduced fitness due to the increased expression of deleterious recessive alleles. By promoting genetic diversity, MHC polymorphism helps maintain population health and resilience.

Challenges of MHC Polymorphism in Organ Transplantation:

1. Matching for Histocompatibility: In organ transplantation, compatibility between donor and recipient MHC molecules is crucial to prevent graft rejection. The high level of polymorphism in MHC genes means that finding a suitable donor with matching MHC alleles can be challenging, particularly for individuals with rare or uncommon MHC haplotypes.
2. Risk of Graft Rejection: Mismatched MHC molecules between donor and recipient can lead to the recognition of the transplanted organ as foreign by the recipient’s immune system, resulting in graft rejection. Even minor differences in MHC alleles can trigger immune responses, highlighting the importance of precise histocompatibility matching in transplantation.
3. Immunosuppressive Therapy: To mitigate the risk of graft rejection, recipients of organ transplants often require long-term immunosuppressive therapy. However, suppressing the immune response increases the risk of infections and other complications, highlighting the delicate balance required in managing post-transplant immune function.

In summary, while MHC polymorphism confers evolutionary advantages by enhancing immune defense and genetic diversity within populations, it poses challenges in organ transplantation due to the need for precise histocompatibility matching to prevent graft rejection. Balancing these considerations is crucial in both understanding the evolutionary significance of MHC diversity and addressing the clinical challenges associated with organ transplantation.

End of Section 3.3

Next Topic: MHC I and MHC II: Summary of Antigen Processing and Presentation

Source: ChatGPT response prompted and edited by Joel Graff.

• Immunology (Table of Contents for Entire Course – FREE!)
  • Other Content for Unit 3: Professional Antigen Presenting Cells